|
Tello-Montoliu A, Ruiz-Nodar JM, Esteve-Pastor MA, Veliz-Martinez A, Orenes-Pinero E, Macias-Villanego MJ, Lozano T, Carrillo-Aleman L, Vicente-Ibarra N, Pernias-Escrig V, Martinez-Martinez JG, Rivera-Caravaca JM, Marin F. Chronic Kidney Disease and Third-Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year. J Clin Pharmacol. 2019 Feb;59(2):295-302. doi: 10.1002/jcph.1318. Epub 2018 Sep 12. PubMed PMID: 30207603.
AÑO: 2019; IF: 2.425
|
|
Vicente-Ibarra N, Marin F, Pernias-Escrig V, Sandin-Rollan M, Nunez-Martinez L, Lozano T, Macias-Villaniego MJ, Carrillo-Aleman L, Candela-Sanchez E, Guzman E, Esteve-Pastor MA, Orenes-Pinero E, Valdes M, Rivera-Caravaca JM, Ruiz-Nodar JM. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome. Eur J Intern Med. 2019 Mar;61:48-53. doi: 10.1016/j.ejim.2018.12.004. Epub 2018 Dec 20. PubMed PMID: 30579651.
AÑO: 2019; IF: 4.329
|
|
Carrillo-Aleman L, Marin F, Rivera-Caravaca JM, Vicente-Ibarra N, Candela-Sanchez E, Esteve-Pastor MA, Lozano T, Sandin-Rollan M, Pernias-Escrig V, Macias M, Quintana-Giner M, Veliz A, Orenes-Pinero E, Martinez-Martinez JG, Ruiz-Nodar JM. Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis. Clin Drug Investig. 2019 Mar;39(3):275-283. doi: 10.1007/s40261-018-0736-z. PubMed PMID: 30623372.
AÑO: 2019; IF: 2.267
|
|
Orenes-Pinero E, Esteve-Pastor MA, Ruiz-Nodar JM, Quintana-Giner M, Veliz-Martinez A, Tello-Montoliu A, Macias-Villanego MJ, Pernias-Escrig V, Vicente-Ibarra N, Carrillo-Aleman L, Sandin-Rollan M, Martinez J, Lozano T, Rivera-Caravaca JM, Marin F. Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease. Minerva Med. 2019 Oct;110(5):410-418. doi: 10.23736/S0026-4806.19.05859-2. Epub 2019 May 6. PubMed PMID: 31081301.
AÑO: 2019; IF: 3.031
|